We have previously extracted a protein from inflammatory mouse granuloma that fully protects normal mice against lethal Listeria monocytogenes infection. We now report that polyclonal antibodies directed against this protein react with a human urinary fraction that also provides full protection of normal mice against L. monocytogenes. Murine monoclonal antibodies completely inhibit the protective activity of the human urinary fraction. We have purified to apparent homogeneity a human glycoprotein of 43 kDa (HGP.43), pI = injection of C57BL/6 mice with Bio-Gel P-100 (Bio-Rad), the gel was withdrawn and the inflammatory cells were recovered by filtration through a 400-mesh screen. The cells were centrifuged (250 x g for 10 min), washed twice with ice-cold Dulbecco's modified Eagle's medium (DMEM), incubated (1 x 106 cells per ml, 0.5 ml per culture tube) for 24 hr, and washed to remove polymorphonuclear cells. Lewis tumor cells (3) were isolated from murine lung metastases and cultured in plastic Petri dishes in DMEM containing 10% (vol/vol) fetal calf serum at 3TC in an atmosphere of 7.5% C02/92.5% air.
signiflcantiy, 8 hr after Listeria infection. In scid mice lacking T and B cells, similar resistance to L. monocytogenes was observed. Inflammatory murine macrophages became cytostatic against Lewis carcinoma cells after incubation with 1.5 nM HGP.43.
An extract of a mouse granuloma protein induced by talc or Bio-Gel P-100 was found to fully protect normal mice against a lethal inoculum of Listeria monocytogenes and to activate peritoneal cells against Lewis carcinoma cells (1-3). A polyclonal antibody prepared against mouse granuloma protein was shown to react with a human protein isolated from the urine of healthy donors. We therefore set out to purify this protein. We have obtained an immunostimulatory protein, separated and purified as a 43-kDa protein, free ofinactive al acid glycoprotein (a1-AGP), which fully protects mice against a lethal inoculum of L. monocytogenes. This protein also activates mouse macrophages against Lewis carcinoma cells.
MATERIALS AND METHODS
Urinary Fractions. Twenty-four-hour urine specimens (2 liters) collected from healthy male and female human donors were stored at -200C. After thawing, the urine was centrifuged at 6900 X g at 40C and the supernatant was concentrated by using an Amicon YM10 ultrafilter with a Mr 10,000 cut-off, to a final volume of 10 ml. Subsequent procedures are discussed in Results.
Mice. BALB/c, OF1 (Iffa Credo, St. Germain sur l'Arbresle, France), C57BL/6, and CB-17 Icr scid mice (Institut Pasteur) were kept under specific pathogen-free conditions. Fate injection of C57BL/6 mice with Bio-Gel P-100 (Bio-Rad), the gel was withdrawn and the inflammatory cells were recovered by filtration through a 400-mesh screen. The cells were centrifuged (250 x g for 10 min), washed twice with ice-cold Dulbecco's modified Eagle's medium (DMEM), incubated ( (Fig.  1) . The active fractions were pooled, dialyzed, and loaded onto a Cibacron blue column to remove contaminating human albumin. The unbound material was then subjected to Ultrogel AcA 44 gel filtration. Two peaks containing the stimulating activity were obtained with apparent molecular masses of 92 and 43 kDa. As previous attempts to characterize this protein showed that the biological activity was not destroyed by trypsin or Pronase, to facilitate its isolation, we hydrolyzed the active fractions with Pronase. Pronase was removed by ultrafiltration, and the concentrate was loaded onto an Ultrogel AcA 54 column. Only fractions 59-69 fully protected mice against a lethal inoculum of L. monocytogenes. When the purified material was analyzed by SDS/ polyacrylamide gel electrophoresis and Coomassie blue staining, one single band migrating with an apparent molecular mass of 43 kDa was detected under reducing and nonreducing conditions (Fig. 2) .
Partial amino acid sequencing of this material revealed that it also contained a1-AGP at 43 kDa, which had no stimulatory activity in our assay. Final purification was performed using immunoaffinity chromatography. The antia1-AGP immunosorbent, prepared according to Pharmacia procedures, was mixed with the urinary protein and incubated for 1 hr under agitation. The antibody beads were transferred to a small column and washed with phosphatebuffered saline. The unbound fraction was pooled, dialyzed, and lyophilized. The absence of a1-AGP was confirmed by an ELISA.
The immunostimulatory activity was removed by passage through a Con A affinity column, indicating that the purified 43-kDa molecule was a glycoprotein [named 43-kDa human glycoprotein (HGP.43)]. By using anthrone reagent, we estimated the amount of carbohydrate to be 15% of the native molecular weight. Preparative flat-bed isoelectric focusing indicated a pI value of 3.2 ± 0.2. The immunostimulatory activity was completely inhibited by the anti-urinary protein monoclonal antibody (Fig. 3) . It is noteworthy that the monoclonal antibody recognized not only the purified HGP.43 but also the 92-kDa protein (Fig. 4) amounts of HGP.43. Target cells 3LL were then added to macrophages at a ratio of 1:10. As shown in Fig. 9 , incubation of Bio-Gel P-100-induced macrophages with 0.06 ,ug of HGP.43 decreased the amount of 1251I-labeled deoxyuridine incorporated into 3LL cells. This effect was clearly dosedependent. The culture supernatant had no cytostatic effect. DISCUSSION We have found that all the human urines tested, obtained from 12 healthy donors, contain two peaks of activity corresponding to proteins with apparent molecular masses of 43 kDa and 92 kDa that are able to protect mice against a lethal inoculum of L. monocytogenes. These two proteins are recognized by the monoclonal antibodies. protein. The 43-kDa species (HGP.43) is glycosylated and Pronase-resistant, and its biological activity is completely neutralized by a specific monoclonal antibody. Among human urinary proteins of similar molecular weight, a1-AGP, also found in our preparations, had no stimulatory effect, since its removal with its specific antibodies did not diminish the anti-L. monocytogenes activity. Furthermore, purified a1-AGP had no stimulatory effect. A 43-kDa epidermal growth factor-related protein has been purified by Gregory (7) from the urine of breast cancer patients, but no biological activity was detected in fractions with an apparent molecular mass of 92 kDa, contrary to the anti-L. monocytogenes activity we describe. In addition, the partial amino acid sequence of HGP.43 differs from the reported sequences of proteins with epidermal growth factor-like activity (8, 9) . Although cytokines, interleukin la (10), interferons ,B (11) and y (12), tumor necrosis factor (13) , granulocyte/ macrophage colony-stimulating factor (14) , have been reported to increase the resistance of mice toward some pathogens, it is unlikely that they account for the biological activity of HGP.43, because their molecular masses are much lower. Since M-CSF, which was shown to have antitumor effects (15) , is a 90-kDa disulfide-bonded homodimer (16), we tested M-CSF in our Listeria infection model and found it had no effect. It, therefore, appears that HGP.43 is distinct from cytokines.
Since HGP.43 is not itself bactericidal but is active in L. monocytogenes-infected scid mice, its activity may be mediated, at least in part, by spleen and liver macrophages. In mice, macrophages are indeed known to be responsible for increased resistance to Listeria (17) . The protective effect of HGP.43 was evident as early as 2 hr after a L. monocytogenes inoculation and was also observed when HGP.43 was injected 8 hr after inoculation. To our knowledge, this is the first report of an immunostimulant activity after L. monocytogenes infection (18 of Bio-Gel P-100 beads into mice were incubated with various amounts of HGP.43 for 24 hr. 3LL cells and macrophages were then added at a ratio of 1:10 and incubated for 24 hr. Cells were then pulsed-labeled with 0.04 ,uCi of 125I-labeled deoxyuridine (specific activity, 5 Ci/mg;
